UCL-TB
@UCLTBUCL-TB is a broad and cross-disciplinary Tuberculosis research network that spans University College London and our partners throughout the world.
Similar User
@LSHTM_TB
@McGill_TB
@UKAPTB
@TBnet_EU
@tb_mac
@UnionConference
@ARNm17
@lshtm_tbmod
@EraseTb
@msf_tb
@Sutherland_TB
@sgschumacher
@kc_horton
@CITC_TB
@TBProof
Today at the #UnionConf2024, Trinh Duong discussed safety of and adherence to levofloxacin to prevent multidrug-resistant #tuberculosis in the TB-CHAMP & VQUIN #ClinicalTrials. Get the full story behind these #TB trials on our podcast. Listen now👇@UCLTB soundcloud.com/trial-talk-pod…
DR-TPT webinar video now available. The edited recording of our webinar event on 'Preventive therapy for drug-resistant tuberculosis' can be seen here: youtube.com/watch?v=iyPx9t… #tuberculosis
#UnionConf2024 starts tomorrow! Our researchers and collaborators will be showcasing their latest #tuberculosis #TB research, including new findings from the TB-CHAMP, VQUIN, SURE and TRUNCATE-TB trials. Check out our schedule of presentations. @UCLTB 👉 mrcctu.ucl.ac.uk/news/news-stor…
DR-TPT webinar video now available. The edited recording of our webinar event on 'Preventive therapy for drug-resistant tuberculosis' can be seen here: youtube.com/watch?v=iyPx9t… @WHO_Europe_TB @LeleRangaka @MRCCTU @UCLGlobalHealth #tuberculosis
Our research was highlighted at the 79th session of the United Nations General Assembly at the High-level Meeting on #AMR, so we thought we'd create a short video highlighting our work in Sudan and Zambia @ucl_global @ffntoumi @AliZumla @JohnTembo1982 Link in thread below...
Today (08 Oct, 2-4pm BST): Join our webinar discussing the new WHO guidelines on preventative therapy for drug-resistant TB (DR-TPT). No need to register, Zoom link: ucl.zoom.us/j/96519210859 #tuberculosis
We were full - new tickets just added
Next week: Join our webinar discussing the new WHO guidelines on preventative therapy for drug-resistant TB (DR-TPT). Register now bit.ly/3NgqwU5 #tuberculosis 📅 Tues 8th October ⏲️2 - 4pm BST
Next week: Join our webinar discussing the new WHO guidelines on preventative therapy for drug-resistant TB (DR-TPT). Register now bit.ly/3NgqwU5 #tuberculosis 📅 Tues 8th October ⏲️2 - 4pm BST
Join the next @UCLTB webinar showcasing the latest updates in preventative therapy for drug-resistant #tuberculosis #TB (DR-TPT). Register now 👉🔗 bit.ly/3NgqwU5 📆 Tuesday 8 October BST 🕑 2pm - 4pm 📍Online
Preventive therapy for drug-resistant TB (DR-TPT): Join our webinar on Tuesday, October 8 to discuss the new WHO guidelines eventbrite.co.uk/e/preventive-t… @UCLGlobalHealth @WHO_Europe_TB @MRCCTU #tuberculosis
Last few days to apply for an exciting clinical fellow position at UCL focusing on early/subclinical TB (closing date 13th Sept) ucl.ac.uk/work-at-ucl/se…
JUST OUT & signaling important changes to treatment of #TB: WHO issues rapid communication on updated guidance for the treatment of drug-resistant #tuberculosis, recommending 4 new regimens buff.ly/3WV7wP7 buff.ly/3MfZcVf
"Standards of Care for people living with non-tuberculous mycobacterial (NTM) disease" - Marc Lipman on why we need them, and how these new standards were developed @NTMNetworkUK @UCLInfectImm youtube.com/watch?v=7gBX6y… #tuberculosis #NTM
"ICE-TB – a new classification for improved TB care and prevention" - @DrAsadZaidi talking at our recent networking meeting @AnnaCoussens @Rein_Houben youtube.com/watch?v=FZF-W3… #tuberculosis
🧵Prognostic tests are being developed to identify people at high risk of developing clinical infectious #tuberculosis in the future, but how should they be managed once diagnosed?
Bedaquiline: what might the future hold? - Review and discussion on how this new TB drug (and future ones) might best be used, considering resistance and access. sciencedirect.com/science/articl… @DrEmilyShaw @UCLGlobalHealth @MRCCTU @UCLInfectImm #tuberculosis
"Access to medicines to TB: Rifapentine" video now online youtube.com/watch?v=b2pRee… @ChristophLange @ferlazzo_g @JBruchfeld @msf_tb @TBnet_EU @UCLGlobalHealth @UCLInfectImm
Thank you to the @UCLTB team James Greenan-Barrett and @mnoursad for this month's discussion on @TheLancet systematic review and meta-analysis of the effectiveness of TPT across age, disease burden and IGRA/TST status by @LeoMarti_EpiTB et al.: 1/4
United States Trends
- 1. SEVENTEEN 1,04 Mn posts
- 2. #UFCMacau 8.173 posts
- 3. woozi 281 B posts
- 4. BIGBANG 29 B posts
- 5. #ArcaneSeason2 45,6 B posts
- 6. Ekko 25,4 B posts
- 7. Kavanagh 2.357 posts
- 8. JUNGKOOK 531 B posts
- 9. Ochoa 6.590 posts
- 10. jikook 10,2 B posts
- 11. #arcane2spoilers 1.371 posts
- 12. scoups 37,1 B posts
- 13. Motta 4.753 posts
- 14. #GDRAGONxMAMA2024 115 B posts
- 15. soyeon 21,6 B posts
- 16. cheol 5.933 posts
- 17. #caitvi 42 B posts
- 18. jeonghan 72,9 B posts
- 19. Kyrie 9.803 posts
- 20. Caleb Love 1.817 posts
Who to follow
-
LSHTM TB Centre
@LSHTM_TB -
McGill TB Centre
@McGill_TB -
UK Academics and Professionals to End TB
@UKAPTB -
TBnet
@TBnet_EU -
TB MAC
@tb_mac -
The Union Conference
@UnionConference -
Arnaud Machelart
@ARNm17 -
LSHTM TB Modelling Group
@lshtm_tbmod -
ERASE-TB
@EraseTb -
MSF_TB
@msf_tb -
Prof Jayne Sutherland
@Sutherland_TB -
Samuel Schumacher
@sgschumacher -
Katherine Horton
@kc_horton -
Curry Tuberculosis
@CITC_TB -
TBProof
@TBProof
Something went wrong.
Something went wrong.